Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.35 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.35 |
| ▸ | PNMT | P11086 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | STAT3 | P40763 | 1/20 | 0.30 |
| ▸ | AR | P10275 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14627617 | 0.80 | PRNP (0.33) | — | |
| SCHEMBL14596133 | 0.80 | CA1 (0.38) | MAPTHTTIMPDH2IMPDH1PNMT | |
| SCHEMBL14627616 | 0.76 | KDM4E (0.31) | — | |
| SCHEMBL195629 | 0.66 | LTA4H (0.43) | CA1CA2 | |
| SCHEMBL11228244 | 0.66 | IMPDH2 (0.59) | MAPTHTTIMPDH2IMPDH1PNMT | |
| SCHEMBL9746966 | 0.66 | PNMT (0.52) | MAPTHTTIMPDH2IMPDH1PNMT | |
| SCHEMBL29489124 | 0.66 | CA1 (0.54) | MAPTHTTIMPDH2IMPDH1PNMT | |
| SCHEMBL45954 | 0.66 | CA1 (0.54) | MAPTHTTIMPDH2IMPDH1PNMT | |
| SCHEMBL7615332 | 0.64 | LTA4H (0.41) | CA1CA2 | |
| SCHEMBL8207199 | 0.64 | MAOB (0.53) | MAPTHTTIMPDH2IMPDH1AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070010695-A1 | Diphosphines, preparation and uses thereof | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2007-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070010695-A1 | Diphosphines, preparation and uses thereof | MPI, ITPA, DCPS | MAPT 3424/4885HTT 3976/4885IMPDH2 296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.